Trading activity:
Reported 24-hour volume equals 0.01% of market capitalization. The local markets snapshot lists Raydium (CLMM) and Meteora among venues with observed trading activity.
YearBull indicators:
YearBull Rank #4,676. Bull Score 49/100.
YB Market Risk Low. This relative market-volatility label is not an investment-safety assessment.
Cycle Early. Observed price change: 24h 0.00% · 7d 1.12% · 30d -24.04%.
Values are descriptive and should be read together rather than as a price forecast.
Read the YearBull methodology.
Snapshot date: 2026-10-27.Data history: 89 daily observations available in the latest 90-day window.
Methodology responsibility:
YearBull’s analytical methodology and presentation rules are developed and maintained by
Alan Zelvin, Founder & Lead Crypto Researcher.
This note identifies responsibility for the methodology; it does not attribute authorship of this data snapshot.
What is Curetopia (CURES)?
Source description
“Join our mission to cure every rare disease on the planet. We’ll stop at nothing to help patient communities no matter how small - boldly venturing wherever the pursuit of life-changing biological breakthroughs may take us. The $CURES utility token will allow rare disease communities to participate in the governance of life-changing research that directly impacts them. Our core operating principle is "by patients, for patients."”
This source-supplied description may contain old, promotional, or unverified claims and is not YearBull editorial analysis.
Official links and contract records appear in Key Facts. Project details can change, so verify current information with the project.
Curetopia (CURES) FAQ
How does CURES relate to governance of rare-disease research?
The project states that CURES is a utility token intended to let rare-disease communities participate in governing research that directly affects them. This presents token holders, particularly members of patient communities, as participants in research-related decision-making. The project does not specify the voting system, eligibility rules, proposal process, or how token influence would be balanced with scientific and clinical expertise.
What does Curetopia mean by its “by patients, for patients” principle?
Curetopia presents “by patients, for patients” as its core operating principle. The stated approach places rare-disease patients and their communities at the center of the project’s research mission, rather than treating them solely as beneficiaries. The project does not explain how this principle would shape research selection, funding decisions, clinical priorities, or participation beyond the proposed governance role for CURES.
What biological objective does Curetopia state for its mission?
Curetopia states that its mission is to help cure every rare disease and pursue life-changing biological breakthroughs. This is a broad ambition rather than a detailed account of a particular therapy, laboratory platform, or clinical program. The project does not specify which biological methods it will use, how research priorities will be selected, or what milestones would demonstrate progress toward that objective.
How does the project characterize its approach to pursuing breakthroughs?
The project says it will pursue life-changing biological breakthroughs boldly and wherever that pursuit leads, while emphasizing support for patient communities regardless of their size. This language positions Curetopia as an ambitious, patient-focused research initiative. It does not set out a defined research pipeline, partnerships, development timetable, funding model, or criteria for evaluating individual breakthrough opportunities.
Curetopia metric comparison
This comparison is a stored snapshot generated 2026-10-23 06:31 UTC from 292 daily observations available from 2025-12-30 through 2026-10-23. It is separate from the latest analytical cards above. Percentiles compare the snapshot value with that day's analytical universe; a higher percentile means a larger observed value, not necessarily a better investment characteristic.
Metric
Snapshot
30d before
90d before
Change vs 30d
Universe percentile
Price
$0.0096012
$0.0112
$0.0106
-14.1%
n/a
Market cap
$378.1K
$439.9K
$415.5K
-14.1%
P54.0
YearBull Rank
#3,558
#2,244
#2,266
Lower by 1,314
P58.4
Bull Score
53/100
48/100
47/100
+5.0 pts
P57.0
Turnover
0.12%
2.09%
1.22%
-2.0 pts
P32.5
YB Market Risk
Low
Low
Low
Unchanged
n/a
Cycle
Early
Early
Early
Unchanged
n/a
Median absolute daily movement 2.72%; distance from the highest local daily price -57.9%; circulating supply change 0.0%. These measurements are descriptive and do not predict future direction.
YearBull Rank update
YearBull Rank now for curetopia: #4676.
Rank timeline (last 365 days)
Rank change (nearest points).
Reading rule: rank #120 sits higher than rank #200.
7d window (2026-10-20): #5238 → #4676 (up by 562).
30d window (2026-09-27): #1366 → #4676 (down by 3310).
Cycle context: If the line stair-steps, the cycle may be driven by discrete inputs. a stable phase often tightens the rank range.
Liquidity angle: If the line only moves on high-volume days, liquidity is a key filter. relative rank is sensitive to who is active in the window.
Listing context: If the line is step-like, watch for discrete market changes. a new route can show up as a step change.
Risk posture: If the curve is step-like, it may be reacting to discrete inputs. range behavior tells more than a single point.
YearBull Rank is a relative placement score used on YearBull to compare a coin against peers within the same dataset. It is meant for comparison and tracking, not certainty.
Editorial note:
This analysis was prepared by the YearBull research team under the direction of
Alan Zelvin,
Founder and Lead Crypto Researcher.
The assessment follows YearBull’s internal research methodology and editorial standards.
Methodology ·
Editorial Policy
Related Research
Continue with contextually connected profiles and category data:
USDFI analysis - nearby market scale in the current dataset.
Stored venue snapshot. Markets last checked: 2026-07-27. Updated on a rolling basis; no fixed refresh date is promised. Venue listings and volumes are stored snapshots, not live quotes.
